Indication for the prophylactic total gastrectomy in the hereditary diffuse gastric cancer in carriers of E-Cadherin mutation. Two observations

被引:0
作者
Godlewski, G. [1 ]
Chiesa, J. [4 ]
Pujol, P. [2 ]
Bourgaud, J. F. [3 ]
Pignodel, C.
Prudhomme, M. [1 ]
机构
[1] CHU, Hop Caremeau, Dept Chirurg Digestive, F-30029 Nimes, France
[2] CHU Montpellier, Hop Arnaud Villeneuve, Serv Genet Med, F-34295 Montpellier, France
[3] CHU, Serv Cytogenet, Nimes, France
[4] CHU, Lab Anatomie Pathol, F-30029 Nimes, France
来源
E-MEMOIRES DE L ACADEMIE NATIONALE DE CHIRURGIE | 2007年 / 6卷 / 01期
关键词
Gastric cancer; E; -Cadherin; CDH1; Hereditary diffuse gastric cancer;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim : The germ-line truncating mutation in the E-Cadherin, CDH1, is identified in 30% of hereditary diffuse gastric cancer (CGDH). The tumors are characterized by a high penetrance with an autosomal dominant pattern of inheritance, predominantly in young people. The endoscopic surveillance, by current methods, is largely ineffective because most tumors are growing up diffusely and quickly. We report the outcomes of 2 asymptomatic patients with the CDH1 mutation who have undergone prophylactic total gastrectomy (GTP). Patients and methods: Two brothers 22 and 33 years old, belonging to a family severely altered by CGD, underwent prophylactic total gastrectomy with Roux en Y reconstruction. Results: Pathologic examination of the stomach shows no evidence of in situ or invasive carcinoma despite multiple samples. There were no operative complications. A 5-5 kg weight loss and diarrhea stabilised in a 3 month period. There were no more complications in the long term. Discussion: Four points are discussed: 1/ The preoperative endoscopic screening for visualisation of carcinoma microfoci and of gastric ectopia in oesophagus. 2/ The interest of the chromoendoscopic surveillance unfortunately limited by size of tumoral foci never detectable if inferior to 4mm. 3/ The precision of the surgical procedure needing a complete removal of gastric mucosa that means GTP in every case. 4/ Regular screening for malignancies of other organs related to the CDH1 mutation (breast, colon-rectum, prostate). 5/ A proposition of therapeutic decisions for CGDH. Conclusion. The GTP indication is often difficult to promote for asymptomatic patients, but the operation avoids any risk of gastric cancer. Nevertheless the GTP cannot dispense patients of regular polyvisceral surveillance.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 31 条
  • [1] Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in CDH1 Mutation Carriers
    Ithurralde-Argerich, Javier
    Rosner, Laura
    Rizzolo, Mariana
    Faerberg, Alejandro
    Puma, Rolando
    Ferro, Diego
    Duque, Camilo
    Kujaruk, Mirta
    Cuenca-Abente, Federico
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2021, 31 (07): : 729 - 737
  • [2] Hereditary Diffuse Gastric Cancer Treated by Prophylactic Total Gastrectomy
    Inaba, Yasunori
    Goda, Kenichi
    Kondo, Masayuki
    Abe, Keiichiro
    Kanamori, Akira
    Suzuki, Tsunehiro
    Tominaga, Keiichi
    Nakagawa, Masatoshi
    Morita, Shinji
    Kojima, Kazuyuki
    Ishida, Kazuyuki
    Irisawa, Atsushi
    INTERNAL MEDICINE, 2024, 63 (02) : 235 - 239
  • [3] Outcomes after Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer
    Pantelis, Dimitrios
    Lingohr, Philipp
    Hueneburg, Robert
    Spier, Isabel
    Vilz, Tim
    Lau, Jan F.
    Nattermann, Jacob
    Aretz, Stefan
    Strassburg, Christian P.
    Kalff, Joerg C.
    ZENTRALBLATT FUR CHIRURGIE, 2020, 145 (01): : 41 - 47
  • [4] Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer
    Barber, M.
    Murrell, A.
    Ito, Y.
    Maia, A-T
    Hyland, S.
    Oliveira, C.
    Save, V.
    Carneiro, F.
    Paterson, A. L.
    Grehan, N.
    Dwerryhouse, S.
    Lao-Sirieix, P.
    Caldas, C.
    Fitzgerald, R. C.
    JOURNAL OF PATHOLOGY, 2008, 216 (03) : 295 - 306
  • [5] Prophylactic total gastrectomy for hereditary diffuse gastric cancer. Review of the literature
    Mastoraki, Aikaterini
    Danias, Nikolaos
    Arkadopoulos, Nikolaos
    Sakorafas, George
    Vasiliou, Pantelis
    Smyrniotis, Vasilios
    SURGICAL ONCOLOGY-OXFORD, 2011, 20 (04): : E223 - E226
  • [6] Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred
    Oliveira, C
    Bordin, MC
    Grehan, N
    Huntsman, D
    Suriano, G
    Machado, JC
    Kiviluoto, T
    Aaltonen, L
    Jackson, CE
    Seruca, R
    Caldas, C
    HUMAN MUTATION, 2002, 19 (05) : 510 - 517
  • [7] E-cadherin mutations and hereditary gastric cancer: Prevention by resection?
    Fitzgerald, RC
    Caldas, C
    DIGESTIVE DISEASES, 2002, 20 (01) : 23 - 31
  • [8] Prophylactic Total Gastrectomy (PTG) for Hereditary Diffuse Gastric Cancer (HDGC): The Newfoundland Experience with 23 Patients
    P. C. Hebbard
    A. MacMillan
    D. Huntsman
    P. Kaurah
    F. Carneiro
    X. Wen
    A. Kwan
    D. Boone
    F. Bursey
    J. Green
    B. Fernandez
    D. Fontaine
    D. A. Wirtzfeld
    Annals of Surgical Oncology, 2009, 16 : 1890 - 1895
  • [9] Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations
    Corso, Giovanni
    Magnoni, Francesca
    Nicastro, Vincenzo
    Bagnardi, Vincenzo
    Trovato, Cristina Maria
    Veronesi, Paolo
    SEMINARS IN ONCOLOGY, 2022, 49 (02) : 130 - 135
  • [10] Is prophylactic gastrectomy indicated for healthy carriers of CDH1 gene mutations associated with hereditary diffuse gastric cancer?
    Munitiz, Vicente
    Jimeno, Pilar
    Ruiz-de-Angulo, David
    Ortiz, Angeles
    Martinez-De-Haro, Luisa F.
    Marin, Miguel
    Cascales, Pedro
    Ruiz-Garcia, Gema
    Ortiz-Ruiz, Eduardo
    Parrilla, Pascual
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (03) : 189 - 192